We studied systemic reactions associated with immunotherapy in a group of 50 patients with mean age 31.4 years. The group consisted of36 women and 14 men who followed a three-year immunotherapy treatment with pollen and mite allergen extracts (HAL-Holland Corporation). A total number of 2550 injections were administered. Eight patients developed systemic reactions; 6 had allergic rhinitis and 2 allergic asthma. None developed severe anaphylaxis. Seven of the systemic reactions occurred immediately after injection while one was a late reaction manifested as generalized urticaria, local edema and rubor at the site of the injection. From the 7 patients who showed an immediate reaction, 5 developed generalized urticaria with local edema and rubor at the site of the injection, while 2 presented with bronchial spasm. We did not observe any reaction when the quantity of the extract injection was reduced by 50%. Our study points out that, in the vast majority of cases, immunotherapy is free of severe systemic reactions. Those that occur are associated with the injection of high-density extracts and none of them is severe.
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Allergen immunotherapy is an effective treatment modality for Hymenoptera hypersensitivity, allergic rhinitis and asthma (1) (2) . Some researchers question or, even, reject the effectiveness of this therapy in asthma, while others claim that it is effective only in specific circumstances (3) (4) (5) (6) . Immunotherapy was first applied in 1911 by Noon to treat seasonal rhinitis (7) . Soon it was evident that treatment was often accompanied by allergic reactions. Since then, research is focused on increasing the effectiveness of immunotherapy while minimizing its side effects: New types of extracts are used to better control systemic allergic reactions; immunotherapy is applied to low-risk individuals only (e.g., individuals without systemic disease, with good cardiopulmonary function and not on medication) and substantial measures are taken in order to reduce the number and the severity of symptoms (8) (9) . The majority of reactions to immunotherapy are mild and fatal reactions are extremely rare (9) (10) . This becomes particularly evident when the high frequency of extract injections during immunotherapy is taken into consideration (10) . According to the International Consensus Report on Diagnosis and Management of Asthma, immunotherapy is recommended when the patient cannot avoid allergens or when the suitable drug treatment, fails to control the symptoms of asthma (11).
MATERIALS AND METHODS
We studied 50 patients who followed a three-year long immunotherapy treatment with extracts of aller-gen pollen and mites. The group's mean age was 31.4 years and it included 36 women and 14 men. Thirty four of the patients (68%) presented with allergic rhinitis only. Twenty one of them presented with seasonal rhinitis caused by pollen allergens: Eight were allergic to grasses, 7 to com pollen, 4 to olive and 2 to parietaria. The remaining 13 (of the 34) presented with continuous rhinitis caused by mites: seven by D. Pteronyssinus, 3 by D. Farinae and 2 by both (D. Pteronyssinus and D. Farinae). Sixteen individuals (32%) of the group presented with both allergic rhinitis and asthma. 10 of them presented with seasonal asthma and seasonal rhinitis caused by pollen from mix com pollen (4 individuals), grasses (2 individuals), parietaria (2 individuals) and olive (2 individuals), while 6 presented with persistent asthma and rhinitis caused by mites: four by D. Pteronyssinus and 2 by D. Farinae.
Immunotherapy
For immunotherapy we used extracts of allergen pollens and mites delivered by subcutaneous injection. We began with low densities, 2 A.U. per week, progressively increasing until we reached 10.000 AU. The vaccines were administered either prior or after the pollen season. The patients remained under observation in the hospital for an hour after injection, while for the rest of the day following their release they could inform us of any adverse reaction. A total of 2550 injections were administered.
RESULTS
In all, 8 patients presented with systemic reactions, 6 of them suffering from allergic rhinitis and 2 from allergic asthma (Tab. I). None of the patients who participated in the study developed a severe anaphylactic reaction. 7 patients showed immediate systemic reactions, while 1 showed a delayed reaction. Of the 7 patients who showed an immediate systemic reaction, 5 developed generalized urticaria with local edema and rubor at the point of the injection. All were from the group presenting with allergic rhinitis. Two patients of the group with allergic asthma, besides urticaria and local edema, presented with wheezing. Late reaction was observed in one patient who suffered from allergic asthma. The symptoms included urticaria, local edema, rubor and wheezing. No reactions were observed when the quantity of the extract injection was reduced by 50%. Regarding skin sensitivity in the 8 patients with systemic reactions, 5 presented with sensitivity to P. Grasses and 3 to Mite Dust (2 to D. Pteronyssinus and 1 to D. Farinae).
DISCUSSION
The systemic allergic reactions in immunotherapy were and continue to be a subject of investigation and concern regarding the clinical application of this type oftherapy. Although severe anaphylactic reactions are very rare and fatal incidents are almost non-existent, they can't be ignored during the application ofimmunotherapy (11-16). However, so long as the patient is kept under close observation for the first 30 minutes following immunotherapy, the risk is substantially minimized. Still, immunotherapy was responsible for 46 fatal incidents in USA during the period between 1945 and 1986 (17) and for 26 fatal incidents in U.K. (Committee on Safety on Medicine CSM) between 1957 and 1986 (12) .
In the present study 8 individuals presented with systemic reactions; 6 of them suffered from allergic rhinitis and 2 from allergic asthma. All the incidents of anaphylactic reactions were observed during the infusion of increased densities ofextract (10.000 AU). None of the reactions was characterized as severe and none ofthe systemic reactions was observed when the quantity of extract injection was reduced by 50%.
In order to avoid the unpleasant incidents and to best cope with them, the patients must be under observation for 30-60 min after the injection. However, systemic anaphylactic reactions are unavoidable and for this reason the attending physician must take all measures necessary to deal with such incidents (15) . The most frequent side effects of immunotherapy are the anaphylactic reaction, the asthma attack, the urticaria, the larynx edema and the angioedema (18) (19) (20) (21) . The side effects are usually observed during the first 30-min after the injection of allergen and rarely hours later (18, 21) .
In order to deal with unpleasant incidents, immunotherapy must be applied by experts in a well equipped medical unit (12) . An adequate oxygen supply together with bronchodilators, antihistamines, corticoids and adrenaline are the basic first aid elements (12) .
In conclusion, the systemic anaphylactic reactions occurred only during the phase of the injection of increased density allergen extracts as all the reactions except for one were immediate. None of these reactions however were severe and all of them disappeared following the administration of antihistamine and B2 agonists drugs. Our conclusions are conforming to the results of a number of studies in different countries during the last 17 years (Tab. II) with the same goal as ours. However, we believe that such studies should be repeated due to the fact that each year a number of new extracts are introduced in the market.
